Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898039079> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2898039079 abstract "The main component of extralysosomal proteolysis is the ubiquitin-proteasome system (UPS), which is supplemented by tripeptidyl peptidase II (TPPII). That system is a target for anticancer strategies by using proteasome inhibitors. Data from several studies on leukemic cells share evidence for the beneficial and potential role of TPPII in cell survivability. Therefore, the aim of this work was to analyze the effect of AAF-cmk, a membrane permeable semi-specific TPPII inhibitor, on human monocytic leukemic cells U937 for translational research.We studied the viability of U937 cells incubated with AAF-cmk using tetrazolium salt reduction assay (MTT) and apoptosis induction by assessing caspase activation by Western blotting and Annexin V binding assays. Transmission electron microscopy (TEM), a gold standard for apoptosis and autophagy detection, was used to assess the ultrastructure of U937 cells.Incubation of cells with AAF-cmk reduced their viability and induced apoptosis by intrinsic pathway. In groups treated with AAF-cmk, activation of caspases 9 and 3 was observed and caspase inhibition by zVDA restored cell viability. TEM revealed the presence of ultrastructural features of apoptosis and authophagy. Moreover, we identified two types of protein aggregates. The first one was found in close proximity to the endoplasmic reticulum (ER) and corresponds to Aggresome-Like Structure (ALIS); however, the second novel type of aggregate was not related to ER elements, but rather to free cytosolic ribosomes. This type did not correspond to the aggresome neither in localization nor the structure, thus we referred these aggregates as ALiSNER (Aggresome-Like Structure Not Associated With the ER).Our results provide novel and important findings about the role of TPPII in protein homeostasis and cell survival. Since semispecific TPPII inhibitor AAF-cmk displays cytotoxic activity against leukemic U937 cells in vitro it can be considered as a potential anticancer agent." @default.
- W2898039079 created "2018-10-26" @default.
- W2898039079 creator A5048301331 @default.
- W2898039079 creator A5070005083 @default.
- W2898039079 creator A5084718890 @default.
- W2898039079 creator A5091618510 @default.
- W2898039079 date "2019-01-08" @default.
- W2898039079 modified "2023-10-18" @default.
- W2898039079 title "Semispecific TPPII inhibitor Ala-Ala-Phe-chloromethylketone (AAF-cmk) displays cytotoxic activity by induction of apoptosis, autophagy and protein aggregation in U937 cells" @default.
- W2898039079 doi "https://doi.org/10.5603/fhc.a2018.0020" @default.
- W2898039079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30294774" @default.
- W2898039079 hasPublicationYear "2019" @default.
- W2898039079 type Work @default.
- W2898039079 sameAs 2898039079 @default.
- W2898039079 citedByCount "1" @default.
- W2898039079 countsByYear W28980390792019 @default.
- W2898039079 crossrefType "journal-article" @default.
- W2898039079 hasAuthorship W2898039079A5048301331 @default.
- W2898039079 hasAuthorship W2898039079A5070005083 @default.
- W2898039079 hasAuthorship W2898039079A5084718890 @default.
- W2898039079 hasAuthorship W2898039079A5091618510 @default.
- W2898039079 hasBestOaLocation W28980390791 @default.
- W2898039079 hasConcept C108634530 @default.
- W2898039079 hasConcept C185592680 @default.
- W2898039079 hasConcept C187436293 @default.
- W2898039079 hasConcept C190283241 @default.
- W2898039079 hasConcept C203522944 @default.
- W2898039079 hasConcept C27740335 @default.
- W2898039079 hasConcept C2777408456 @default.
- W2898039079 hasConcept C2780783641 @default.
- W2898039079 hasConcept C31573885 @default.
- W2898039079 hasConcept C33195913 @default.
- W2898039079 hasConcept C53227056 @default.
- W2898039079 hasConcept C55493867 @default.
- W2898039079 hasConcept C86803240 @default.
- W2898039079 hasConcept C95444343 @default.
- W2898039079 hasConcept C98424977 @default.
- W2898039079 hasConceptScore W2898039079C108634530 @default.
- W2898039079 hasConceptScore W2898039079C185592680 @default.
- W2898039079 hasConceptScore W2898039079C187436293 @default.
- W2898039079 hasConceptScore W2898039079C190283241 @default.
- W2898039079 hasConceptScore W2898039079C203522944 @default.
- W2898039079 hasConceptScore W2898039079C27740335 @default.
- W2898039079 hasConceptScore W2898039079C2777408456 @default.
- W2898039079 hasConceptScore W2898039079C2780783641 @default.
- W2898039079 hasConceptScore W2898039079C31573885 @default.
- W2898039079 hasConceptScore W2898039079C33195913 @default.
- W2898039079 hasConceptScore W2898039079C53227056 @default.
- W2898039079 hasConceptScore W2898039079C55493867 @default.
- W2898039079 hasConceptScore W2898039079C86803240 @default.
- W2898039079 hasConceptScore W2898039079C95444343 @default.
- W2898039079 hasConceptScore W2898039079C98424977 @default.
- W2898039079 hasLocation W28980390791 @default.
- W2898039079 hasLocation W28980390792 @default.
- W2898039079 hasOpenAccess W2898039079 @default.
- W2898039079 hasPrimaryLocation W28980390791 @default.
- W2898039079 hasRelatedWork W1843225307 @default.
- W2898039079 hasRelatedWork W1969468821 @default.
- W2898039079 hasRelatedWork W2029107211 @default.
- W2898039079 hasRelatedWork W2080186188 @default.
- W2898039079 hasRelatedWork W2161892192 @default.
- W2898039079 hasRelatedWork W2364918289 @default.
- W2898039079 hasRelatedWork W2366982793 @default.
- W2898039079 hasRelatedWork W2374220218 @default.
- W2898039079 hasRelatedWork W2795168650 @default.
- W2898039079 hasRelatedWork W341433189 @default.
- W2898039079 isParatext "false" @default.
- W2898039079 isRetracted "false" @default.
- W2898039079 magId "2898039079" @default.
- W2898039079 workType "article" @default.